SMS Pharmaceuticals Ltd — Investor Relations & Filings
SMS Pharmaceuticals Ltd specializes in the development and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. The organization operates multiple manufacturing units and research centers, maintaining compliance with international regulatory standards including USFDA approvals. Its core product portfolio covers therapeutic areas such as anti-ulcerants, anti-migraine agents, anti-hypertensives, and anti-retrovirals. Beyond its proprietary product line, the company provides Contract Research and Manufacturing Services (CRAMS), offering expertise in process development, chemical synthesis, and analytical validation. The company focuses on delivering high-quality chemical solutions through integrated research and development capabilities, supporting global supply chains with a commitment to technical excellence and operational efficiency.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| General Updates | 2026-05-23 | English | |
| Investor Presentation | 2026-05-23 | English | |
| Press Release on Financial Results for the year ended 31.03.2026 | 2026-05-23 | English | |
| Press Release | 2026-05-23 | English | |
| Intimation of Investor Call | 2026-05-22 | English | |
| Analysts/Institutional Investor Meet/Con. Call Updates | 2026-05-22 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46894503 | General Updates | 2026-05-23 | English | ||
| 46893043 | Investor Presentation | 2026-05-23 | English | ||
| 46891417 | Press Release on Financial Results for the year ended 31.03.2026 | 2026-05-23 | English | ||
| 46894540 | Press Release | 2026-05-23 | English | ||
| 46811545 | Intimation of Investor Call | 2026-05-22 | English | ||
| 46802004 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-05-22 | English | ||
| 46797616 | Please find the enclosure | 2026-05-22 | English | ||
| 46797148 | Address Change | 2026-05-22 | English | ||
| 46797192 | Statement of deviation(s) or variation(s) under Reg. 32 | 2026-05-22 | English | ||
| 46797694 | Please find the enclosure | 2026-05-22 | English | ||
| 46797751 | Re-appointment of Auditors of the Company | 2026-05-22 | English | ||
| 46797266 | Change in Auditors | 2026-05-22 | English | ||
| 46788008 | Dividend | 2026-05-22 | English | ||
| 46788002 | Declaration of Dividend for the financial year 2025-26 | 2026-05-22 | English | ||
| 46784400 | Integrated Filing- Financial | 2026-05-22 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Altimmune, Inc.
Clinical-stage biopharma developing peptide therapeutics fo…
|
ALT | US | Manufacturing |
|
Alto Neuroscience, Inc.
Develops precision medicines for neuropsychiatric condition…
|
ANRO | US | Manufacturing |
|
ALUMIS INC.
Clinical-stage biopharma developing precision medicines for…
|
ALMS | US | Manufacturing |
|
Alvotech Holdings S.A
A biotechnology company developing and manufacturing biosim…
|
ALVO | LU | Manufacturing |
|
ALX ONCOLOGY HOLDINGS INC
Clinical-stage immuno-oncology company developing therapies…
|
ALXO | US | Manufacturing |
|
Alzamend Neuro, Inc.
Develops treatments for neurodegenerative diseases and psyc…
|
ALZN | US | Manufacturing |
|
Alzinova AB
Clinical-stage biopharma developing immunotherapies for Alz…
|
ALZ | SE | Manufacturing |
|
Amanta Healthcare Limited
Manufactures sterile liquid formulations using advanced Blo…
|
AMANTA | IN | Manufacturing |
|
AMARIN CORP PLC\UK
Develops and commercializes therapeutics to improve cardiov…
|
AMRN | US | Manufacturing |
|
Ambalal Sarabhai Enterprise Ltd.
Manufactures pharmaceuticals, APIs, fine chemicals, and dia…
|
AMBALALSA | IN | Manufacturing |
SMS Pharmaceuticals Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/62302/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=62302 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=62302 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=62302 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 62302}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for SMS Pharmaceuticals Ltd (id: 62302)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.